<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Overview of endoscopic retrograde cholangiopancreatography (ERCP) in adults</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Overview of endoscopic retrograde cholangiopancreatography (ERCP) in adults</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Overview of endoscopic retrograde cholangiopancreatography (ERCP) in adults</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Andrea Tringali, MD, PhD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Guido Costamagna, MD, FACG</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">John R Saltzman, MD, FACP, FACG, FASGE, AGAF</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kristen M Robson, MD, MBA, FACG</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Oct 31, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Endoscopic retrograde cholangiopancreatography (ERCP) is an advanced endoscopic procedure in which a specialized side-viewing upper endoscope is guided into the duodenum, allowing for instruments to be passed through the ampulla of Vater and into the biliary and pancreatic ducts. The ducts are opacified by injecting a contrast medium, thereby permitting radiographic visualization and therapeutic interventions. ERCP-guided interventions are used for management of a variety of pancreaticobiliary disorders (eg, removal of bile duct stones, relief of biliary obstruction). </p><p>ERCP is a complex procedure that requires specialized training and experience, and it is associated with higher rates of serious complications than other endoscopic procedures (eg, upper endoscopy, colonoscopy). It is important to use strategies to prevent ERCP-related complications and to recognize complications early so that treatment can be initiated.</p><p>This topic will provide an overview of ERCP including indications, patient preparation, post-procedure care, and complications.</p><p>Specific ERCP-guided interventions are discussed separately:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/13925.html" rel="external">"Endoscopic stenting for malignant biliary obstruction"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/631.html" rel="external">"Endoscopic balloon dilation for removal of bile duct stones"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/637.html" rel="external">"Endoscopic management of postcholecystectomy biliary complications"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/2658.html" rel="external">"Pancreatic stenting at endoscopic retrograde cholangiopancreatography (ERCP): Indications, techniques, and complications"</a>.)</p><p></p><p class="headingAnchor" id="H2"><span class="h1">PATIENT SELECTION</span></p><p class="headingAnchor" id="H2565978260"><span class="h2">Indications</span><span class="headingEndMark"> — </span>The role of ERCP in managing pancreaticobiliary disorders is mostly a therapeutic one because other methods of diagnostic testing (eg, magnetic resonance imaging with magnetic resonance cholangiopancreatography, endoscopic ultrasound) provide high diagnostic accuracy without the risks associated with ERCP (eg, acute pancreatitis) [<a href="#rid1">1</a>]. In addition, the use of ERCP appears be increasing with time, despite the focus on therapeutic indications only [<a href="#rid2">2</a>]. </p><p>Indications for ERCP-guided interventions include [<a href="#rid3">3-5</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Choledocholithiasis (see  <a class="medical medical_review" href="/d/html/13922.html" rel="external">"Choledocholithiasis: Clinical manifestations, diagnosis, and management"</a>). </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Acute cholangitis (see  <a class="medical medical_review" href="/d/html/658.html" rel="external">"Acute cholangitis: Clinical manifestations, diagnosis, and management"</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Drainage of malignant biliary obstruction (eg, pancreatic cancer, hilar cholangiocarcinoma) (see  <a class="medical medical_review" href="/d/html/13925.html" rel="external">"Endoscopic stenting for malignant biliary obstruction"</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Post-surgical biliary complications (eg, biliary stricture, bile leak) (see  <a class="medical medical_review" href="/d/html/4596.html" rel="external">"Liver transplantation in adults: Endoscopic management of biliary adverse events"</a> and  <a class="medical medical_review" href="/d/html/637.html" rel="external">"Endoscopic management of postcholecystectomy biliary complications"</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Management of complications related to acute or chronic pancreatitis (eg, pancreatic duct stricture, pancreatic stones) (see  <a class="medical medical_review" href="/d/html/2658.html" rel="external">"Pancreatic stenting at endoscopic retrograde cholangiopancreatography (ERCP): Indications, techniques, and complications"</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Extrahepatic biliary strictures related to primary sclerosing cholangitis (see  <a class="medical medical_review" href="/d/html/661.html" rel="external">"Primary sclerosing cholangitis in adults: Management", section on 'Endoscopic therapy'</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Endoscopic therapy for some patients with sphincter of Oddi dysfunction.</p><p></p><p class="headingAnchor" id="H3734260339"><span class="h2">Contraindications</span><span class="headingEndMark"> — </span>ERCP is usually contraindicated in conditions where the risk of complications is high, and thus, the risks outweigh the potential benefits of the procedure. However, some patients who are at high risk for complications, such as those with acute severe cholangitis associated with sepsis and cardiorespiratory dysfunction, may undergo interventional ERCP to relieve biliary obstruction because of the high risk of mortality related to severe cholangitis. (See  <a class="medical medical_review" href="/d/html/658.html" rel="external">"Acute cholangitis: Clinical manifestations, diagnosis, and management", section on 'Prognosis'</a>.)</p><p>Relative contraindications to ERCP include:</p><p class="bulletIndent1"><span class="glyph">●</span>Patients who cannot tolerate monitored anesthesia care or general anesthesia (see  <a class="medical medical_review" href="/d/html/105511.html" rel="external">"Anesthesia for gastrointestinal endoscopy in adults"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with an untreated hemostatic disorder who are deemed to be at high risk for bleeding by the advanced endoscopist (see  <a class="medical medical_review" href="/d/html/2553.html" rel="external">"Gastrointestinal endoscopy in patients with disorders of hemostasis"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with gastrointestinal (luminal) obstruction may undergo endoscopy, but the examination is limited to an area proximal to the level of obstruction (see  <a class="medical medical_review" href="/d/html/2676.html" rel="external">"Enteral stents for the palliation of malignant gastroduodenal obstruction"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with type III sphincter of Oddi dysfunction  </p><p></p><p class="headingAnchor" id="H70259351"><span class="h1">PATIENT PREPARATION</span><span class="headingEndMark"> — </span>The preprocedure preparation for patients undergoing ERCP is similar to that described for patients undergoing upper gastrointestinal endoscopy with the following additions: </p><p class="bulletIndent1"><span class="glyph">●</span>Preprocedure testing – Most patients who require interventional ERCP will have had laboratory tests (eg, complete blood count and prothrombin time/international normalized ratio, liver biochemical tests, pancreatic enzymes) as part of the diagnostic evaluation for the underlying condition, thereby mitigating the need additional laboratory testing. (See  <a class="medical medical_review" href="/d/html/13928.html" rel="external">"Overview of upper gastrointestinal endoscopy (esophagogastroduodenoscopy)", section on 'Patient preparation'</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Adjusting medications – The management of antiplatelet and anticoagulant therapy in patients undergoing ERCP is typically individualized, managed in conjunction with the prescribing specialist, and is discussed separately. (See  <a class="medical medical_review" href="/d/html/2632.html" rel="external">"Management of antiplatelet agents in patients undergoing endoscopic procedures"</a> and  <a class="medical medical_review" href="/d/html/2609.html" rel="external">"Management of anticoagulants in patients undergoing endoscopic procedures"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Sedation/anesthesia – The procedure is typically performed using monitored anesthesia care or general anesthesia. Anesthetic management for endoscopic procedures including preprocedure fasting is discussed separately. (See  <a class="medical medical_review" href="/d/html/105511.html" rel="external">"Anesthesia for gastrointestinal endoscopy in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Antibiotic prophylaxis – The use of antibiotic prophylaxis is determined by patient's risk factors for procedure-related infection. For example, patients with malignant hilar obstruction in whom complete biliary drainage is unlikely receive antibiotic prophylaxis  (<a class="graphic graphic_table graphicRef99536" href="/d/graphic/99536.html" rel="external">table 1</a>). The risk factors for infection and prophylactic antibiotic regimens are discussed separately. (See  <a class="medical medical_review" href="/d/html/2545.html" rel="external">"Antibiotic prophylaxis for gastrointestinal endoscopic procedures"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with allergy to radiologic contrast – Adverse reactions to contrast agents for ERCP are very rare as contrast agents are not injected intravenously but instead are used to opacify the biliary and pancreatic ducts [<a href="#rid6">6,7</a>]. Thus, use of premedication varies in clinical practice because it is uncertain whether it is beneficial for preventing adverse reactions related to contrast. We typically reserve the use of premedication for patients with a history of anaphylaxis or severe adverse reaction (eg, bronchospasm, diffuse erythema with hypotension) related to iodinated contrast, and these issues are discussed in more detail separately. (See  <a class="medical medical_review" href="/d/html/113083.html" rel="external">"Patient evaluation prior to oral or iodinated intravenous contrast for computed tomography"</a> and  <a class="medical medical_review" href="/d/html/638.html" rel="external">"Adverse events related to endoscopic retrograde cholangiopancreatography (ERCP) in adults", section on 'Contrast allergy and other contrast-related issues'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with cardiac implantable electronic devices – During ERCP, electrocautery using monopolar current is used for sphincterotomy. Patients with cardiac implantable electronic devices require a preprocedure evaluation for compatibility with monopolar current, and this is discussed separately. (See  <a class="medical medical_review" href="/d/html/94293.html" rel="external">"Perioperative management of patients with a pacemaker or implantable cardioverter-defibrillator"</a>.) </p><p></p><p class="headingAnchor" id="H84322493"><span class="h1">INFORMED CONSENT</span><span class="headingEndMark"> — </span>The process of informed procedural consent is based upon the interactions between the clinician and the patient and includes a clear explanation of the procedure and its risks, benefits, and alternatives. Informed procedural consent is discussed in more detail separately. (See  <a class="medical medical_review" href="/d/html/15076.html" rel="external">"Informed procedural consent"</a>.)</p><p class="headingAnchor" id="H467094451"><span class="h1">PROCEDURE</span></p><p class="headingAnchor" id="H2372791531"><span class="h2">Positioning</span><span class="headingEndMark"> — </span>ERCP is typically performed with the patient in the prone position. However, ERCP can be performed in the supine position if needed. As an example, supine positioning may be required for patients with a recent abdominal surgical wound or with external drains or tubes. The supine position may be also chosen to improve fluoroscopic visualization of hilar anatomy or to facilitate airway management.</p><p>Performing ERCP with the patient in the supine position may be more technically challenging for some endoscopists as some adjustment in endoscopic technique is required. However, data have suggested that outcomes (ie, cannulation rates, procedure times) were not significantly different for ERCP that is performed with the patient in the supine position compared with the prone position [<a href="#rid8">8</a>].</p><p>ERCP can be performed with the patient in the left lateral decubitus position which may be more comfortable for some patients, particularly those with conditions such as limited cervical movement, pregnancy, or recent abdominal surgery. However, interpretation of fluoroscopic images of the main hepatic confluence, intrahepatic bile ducts, and pancreatic duct is not as reliable in the left lateral position, and thus the left lateral position is not generally used during ERCP [<a href="#rid9">9-11</a>].</p><p class="headingAnchor" id="H2451967021"><span class="h2">Gas insufflation</span><span class="headingEndMark"> — </span>We use carbon dioxide for insufflating the gastrointestinal lumen during ERCP, and use of carbon dioxide is increasingly common during gastrointestinal endoscopy. (See  <a class="medical medical_review" href="/d/html/13927.html" rel="external">"Overview of colonoscopy in adults", section on 'Colonoscope advancement and mucosal inspection'</a>.) </p><p>Gas insufflation distends the bowels and may lead to post-ERCP abdominal pain. However, carbon dioxide is rapidly absorbed by the gastrointestinal mucosa and delivered to the lungs by the circulation, whereas ambient air is not readily absorbed [<a href="#rid12">12</a>]. </p><p>Data have suggested that carbon dioxide insufflation during ERCP resulted in less post-procedure pain but without increased risk of cardiopulmonary complications [<a href="#rid13">13,14</a>]. In a meta-analysis of nine trials including 1014 patients who underwent ERCP, carbon dioxide insufflation resulted in less abdominal pain at one hour, three hours, and six hours after ERCP compared with air insufflation [<a href="#rid13">13</a>]. Carbon dioxide use resulted in lower risk of complications overall (odds ratio [OR] 0.59, 95% CI 0.37-0.93). A concern with carbon dioxide insufflation has been the possible association with increased risk of hypercapnia [<a href="#rid15">15</a>], but this has not been supported by most studies [<a href="#rid16">16-18</a>]. </p><p class="headingAnchor" id="H2905707228"><span class="h1">POST-PROCEDURE CARE</span><span class="headingEndMark"> — </span>After the procedure, patients are recovered from anesthesia, and this is discussed separately. (See  <a class="medical medical_review" href="/d/html/105511.html" rel="external">"Anesthesia for gastrointestinal endoscopy in adults", section on 'Post-anesthesia care'</a>.)</p><p>Routine post-procedure care includes:</p><p class="bulletIndent1"><span class="glyph">●</span>Post-procedure monitoring – For patients who undergo ERCP on an outpatient basis, the duration of post-procedure monitoring ranges from two to six hours to observe the patient for early complications such as pancreatitis. Some advanced endoscopists routinely admit patients to the hospital for one night after the procedure.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Diet – Following the procedure, most advanced endoscopists instruct patients who are at increased risk for complications such as pancreatitis to resume a diet limited to clear liquids for the first 24 hours after ERCP [<a href="#rid19">19</a>]. Such patients may then resume their normal diet if they tolerate clear liquids. Risk factors for post-ERCP pancreatitis (eg, difficult cannulation of the ampulla, prior history of pancreatitis) are discussed separately. (See  <a class="medical medical_review" href="/d/html/629.html" rel="external">"Post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis", section on 'Definition and epidemiology'</a>.)</p><p></p><p class="bulletIndent1">Patients without risk factors for complications are instructed to consume clear liquids only for four to six hours after ERCP (or for the remainder of the day if the procedure was performed in the late afternoon). If clear liquids are tolerated, then patients may advance to solid food [<a href="#rid20">20</a>].</p><p></p><p class="headingAnchor" id="H84322341"><span class="h1">ADVERSE EVENTS</span><span class="headingEndMark"> — </span>Overall rates of and risk factors for ERCP-related adverse events are discussed separately. (See  <a class="medical medical_review" href="/d/html/638.html" rel="external">"Adverse events related to endoscopic retrograde cholangiopancreatography (ERCP) in adults"</a>.)</p><p class="headingAnchor" id="H427542188"><span class="h2">Specific ERCP-related complications</span><span class="headingEndMark"> — </span>The most frequently encountered serious post-ERCP complications are pancreatitis, bleeding, infection, and perforation [<a href="#rid21">21-24</a>].</p><p class="headingAnchor" id="H12"><span class="h3">Pancreatitis</span><span class="headingEndMark"> — </span>Acute pancreatitis is a serious complication of ERCP that may result from mechanical injury to the pancreatic duct, hydrostatic injury from contrast injection or guidewire manipulation. Risk factors, prevention, and management of post-ERCP pancreatitis are discussed separately. (See  <a class="medical medical_review" href="/d/html/629.html" rel="external">"Post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis"</a>.)</p><p class="headingAnchor" id="H13"><span class="h3">Bleeding</span><span class="headingEndMark"> — </span>Bleeding during ERCP is typically related to instrumentation such as biliary and/or pancreatic sphincterotomy. Prevention and management of post-ERCP bleeding are discussed separately. (See  <a class="medical medical_review" href="/d/html/636.html" rel="external">"Post-endoscopic retrograde cholangiopancreatography (ERCP) bleeding"</a>.)</p><p class="headingAnchor" id="H14"><span class="h3">Infection</span><span class="headingEndMark"> — </span>Infections occurring after ERCP may be related to incomplete drainage of an infected biliary system, obstruction of the cystic duct, infected pancreatic fluid collection, or rarely, contaminated endoscopic equipment. The prevention and management of infectious complications related to ERCP are discussed separately:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/641.html" rel="external">"Infectious adverse events related to endoscopic retrograde cholangiopancreatography (ERCP)"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/2672.html" rel="external">"Preventing infection transmitted by gastrointestinal endoscopy"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/2545.html" rel="external">"Antibiotic prophylaxis for gastrointestinal endoscopic procedures"</a>.)</p><p></p><p class="headingAnchor" id="H2969852191"><span class="h3">Perforation</span><span class="headingEndMark"> — </span>ERCP may be complicated by perforation of the esophagus, stomach, or small intestine. The risk factors, diagnosis, and management of post-ERCP perforation are presented separately. (See  <a class="medical medical_review" href="/d/html/634.html" rel="external">"Post-ERCP perforation"</a>.)</p><p class="headingAnchor" id="H669373262"><span class="h3">Other adverse events</span><span class="headingEndMark"> — </span>Several rare complications have been associated with ERCP including gas embolism, pneumothorax, and pneumoperitoneum. These and other less common complications are discussed separately. (See  <a class="medical medical_review" href="/d/html/638.html" rel="external">"Adverse events related to endoscopic retrograde cholangiopancreatography (ERCP) in adults", section on 'Less common adverse events'</a>.) </p><p class="headingAnchor" id="H558283168"><span class="h2">Sphincterotomy-related complications</span><span class="headingEndMark"> — </span>Biliary sphincterotomy refers to cutting the biliary sphincter and intraduodenal segment of the common bile duct using high frequency current applied with a sphincterotome that is inserted into the papilla [<a href="#rid25">25</a>]. Sphincterotomy is often used to facilitate biliary interventions such a stone extraction.</p><p>Rates of sphincterotomy-related complications overall have ranged from 3 to 12 percent [<a href="#rid26">26</a>]. Sphincterotomy-related perforations are typically retroperitoneal. Other interventions that are performed in addition to sphincterotomy (eg, stone extraction, biliary stent placement) may also contribute to the risk of complications. Rates of specific sphincterotomy-related complications (eg, bleeding, pancreatitis) are discussed separately. (See  <a class="medical medical_review" href="/d/html/640.html" rel="external">"Endoscopic biliary sphincterotomy"</a>.)</p><p class="headingAnchor" id="H4122854411"><span class="h2">Anesthesia-related complications</span><span class="headingEndMark"> — </span>Complications related to procedural sedation and anesthesia (eg, hypoxemia, hypotension) are discussed separately [<a href="#rid27">27</a>]. (See  <a class="medical medical_review" href="/d/html/105511.html" rel="external">"Anesthesia for gastrointestinal endoscopy in adults", section on 'Complications'</a> and  <a class="medical medical_review" href="/d/html/2599.html" rel="external">"Adverse events related to procedural sedation for gastrointestinal endoscopy in adults"</a>.)</p><p class="headingAnchor" id="H2739583388"><span class="h1">SPECIAL POPULATIONS</span></p><p class="headingAnchor" id="H3100981641"><span class="h2">Patients with surgically-altered anatomy</span><span class="headingEndMark"> — </span>For patients with surgically-altered anatomy (eg, Roux-en-Y anatomy), it is frequently challenging or impossible to access the ampulla of Vater (or the bilioenteric/pancreatoenteric anastomosis) using a standard duodenoscope due to the length of the small bowel that must be traversed. To overcome these issues, innovative approaches to ERCP have been developed. These approaches are discussed separately:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/676.html" rel="external">"Endoscopic retrograde cholangiopancreatography (ERCP) after Billroth II reconstruction"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/15864.html" rel="external">"ERCP in patients with Roux-en-Y anatomy"</a>.)</p><p></p><p class="headingAnchor" id="H1007936864"><span class="h2">Pregnant patients</span><span class="headingEndMark"> — </span>Pregnancy is associated with an increased risk of gallstone formation, and some pregnant patients develop complications related to gallstones that require intervention. The approach to performing ERCP in pregnant patients while minimizing risk to the mother and fetus are discussed separately. (See  <a class="medical medical_review" href="/d/html/653.html" rel="external">"Endoscopic retrograde cholangiopancreatography (ERCP) in pregnancy"</a>.)</p><p class="headingAnchor" id="H29"><span class="h1">QUALITY INDICATORS</span><span class="headingEndMark"> — </span>Multiple quality indicators have been proposed for ERCP [<a href="#rid4">4,28</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Documenting appropriate indication for ERCP (performance target &gt;90 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Achieving cannulation of the ducts of interest in patients with a native papilla and without surgically-altered anatomy (performance target &gt;90 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Achieving extraction of common bile duct stones that are &lt;1 cm in size in patients with normal bile duct anatomy (performance target ≥90 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Successful stent insertion for patients with nonhilar biliary obstruction (performance target ≥90 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Tracking rates of post-ERCP pancreatitis (no specific benchmark was provided)</p><p></p><p>Proficiency in ERCP is based on achievement of cannulation, accurately interpreting endoscopic and radiologic images, and successful sphincterotomy and stent placement when necessary. Determination of competency varies by geographic region. Specialty societies have published guidance on privileging and credentialing [<a href="#rid29">29</a>], and guidelines from the American Society for Gastrointestinal Endoscopy (ASGE) can be found <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.asge.org%2Fdocs%2Fdefault-source%2Feducation%2Fpractice_guidelines%2Fguidelines_privileging_credentialing_proctoring.pdf%3Fsfvrsn%3Da1d5e851_8&amp;token=1T6Y%2FNVICcjIT9fv7E6GYH%2FyiTgKXBargDhrOfIsrIxncRwrANJ11%2BJ%2BUUw0Bxe8Uy8vqReyH49JHIsxL3qt4LWqR2OST%2FeBabtbOkD4uWJdpgWPOe19jlB7RJn6ba3YiVVpgf7BkkXe0JitjIe4DQKUgwaYkcIOz36EzSiqdZY%3D&amp;TOPIC_ID=632" target="_blank">here</a>. </p><p class="headingAnchor" id="H2431847983"><span class="h1">MALPRACTICE</span><span class="headingEndMark"> — </span>Little is known about the financial burden of specific endoscopic complications in terms of claims against clinicians for compensation, but studies have looked at malpractice claims related to endoscopic procedures [<a href="#rid30">30-33</a>]. In a database study including 1901 endoscopy-related closed claims from a trade association of professional liability insurance carriers, 217 closed claims (11 percent) involved ERCP, while colonoscopy cases were the most commonly reported (788 claims [41 percent]) [<a href="#rid32">32</a>]. In terms of mean payment amount, ERCP ranked the highest per claim (USD $374,794). Claim payments for colonoscopy and ERCP increased over time, with an average increase of 16 percent per year for colonoscopy and 22 percent per year for ERCP. </p><p class="headingAnchor" id="H1133915453"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/118263.html" rel="external">"Society guideline links: Endoscopic retrograde cholangiopancreatography (ERCP)"</a>.)</p><p class="headingAnchor" id="H1894590155"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/d/html/2006.html" rel="external">"Patient education: ERCP (endoscopic retrograde cholangiopancreatography) (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H31"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Background</strong> – Endoscopic retrograde cholangiopancreatography (ERCP) is an advanced endoscopic procedure in which a specialized side-viewing upper endoscope is guided into the duodenum, allowing for instruments to be passed through the ampulla of Vater and into the biliary and pancreatic ducts. The ducts are opacified by injecting a contrast medium, thereby permitting radiographic visualization and therapeutic interventions. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Indications </strong>– The role of ERCP in managing pancreaticobiliary disorders is mostly a therapeutic one because other methods of diagnostic testing (eg, magnetic resonance cholangiopancreatography, endoscopic ultrasound) provide high diagnostic accuracy without the risk of ERCP-related complications. Indications for ERCP-guided interventions include choledocholithiasis, endoscopic therapy for biliary strictures, and drainage of malignant biliary obstruction. (See <a class="local">'Indications'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Procedure </strong>– ERCP is typically performed with the patient in the prone position. However, ERCP can be performed in the supine position if needed (eg, patients with a recent abdominal surgical wound). (See <a class="local">'Procedure'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Adverse events</strong> – ERCP is generally regarded as a safe procedure. However, ERCP is associated with higher rates of complications than most other endoscopic procedures despite technologic advances, adherence to safety protocols, and advanced endoscopic training programs. (See  <a class="medical medical_review" href="/d/html/638.html" rel="external">"Adverse events related to endoscopic retrograde cholangiopancreatography (ERCP) in adults"</a>.)</p><p></p><p class="bulletIndent1">The most frequently encountered serious ERCP-related adverse events are:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Pancreatitis (see  <a class="medical medical_review" href="/d/html/629.html" rel="external">"Post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Bleeding (see  <a class="medical medical_review" href="/d/html/636.html" rel="external">"Post-endoscopic retrograde cholangiopancreatography (ERCP) bleeding"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Infection (see  <a class="medical medical_review" href="/d/html/641.html" rel="external">"Infectious adverse events related to endoscopic retrograde cholangiopancreatography (ERCP)"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Perforation (see  <a class="medical medical_review" href="/d/html/634.html" rel="external">"Post-ERCP perforation"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Quality indicators </strong>– Quality indicators can be monitored to help assure that ERCP is performed safely. Quality indicators may include documentation of the rates of cannulation of the common bile duct, extraction of common bile duct stones, successful stent insertion, and post-ERCP pancreatitis. (See <a class="local">'Quality indicators'</a> above.)</p><p></p><p class="headingAnchor" id="H3469064596"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Silvano Loperfido, MD, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">ASGE Standards of Practice Committee, Chandrasekhara V, Khashab MA, et al. Adverse events associated with ERCP. Gastrointest Endosc 2017; 85:32.</a></li><li><a class="nounderline abstract_t">Coelho-Prabhu N, Shah ND, Van Houten H, et al. Endoscopic retrograde cholangiopancreatography: utilisation and outcomes in a 10-year population-based cohort. BMJ Open 2013; 3.</a></li><li><a class="nounderline abstract_t">ASGE Standards of Practice Committee, Early DS, Ben-Menachem T, et al. Appropriate use of GI endoscopy. Gastrointest Endosc 2012; 75:1127.</a></li><li><a class="nounderline abstract_t">Adler DG, Lieb JG 2nd, Cohen J, et al. Quality indicators for ERCP. Am J Gastroenterol 2015; 110:91.</a></li><li><a class="nounderline abstract_t">Buxbaum JL, Buitrago C, Lee A, et al. ASGE guideline on the management of cholangitis. Gastrointest Endosc 2021; 94:207.</a></li><li><a class="nounderline abstract_t">Pan JJ, Draganov PV. Adverse reactions to iodinated contrast media administered at the time of endoscopic retrograde cholangiopancreatography (ERCP). Inflamm Allergy Drug Targets 2009; 8:17.</a></li><li><a class="nounderline abstract_t">Trottier-Tellier F, Harvey L, Baillargeon JD. Risk Evaluation of Endoscopic Retrograde Cholangiopancreatography-Related Contrast Media Allergic-Like Reaction: A Single Centre Experience. Can J Gastroenterol Hepatol 2018; 2018:6296071.</a></li><li><a class="nounderline abstract_t">Tringali A, Mutignani M, Milano A, et al. No difference between supine and prone position for ERCP in conscious sedated patients: a prospective randomized study. Endoscopy 2008; 40:93.</a></li><li><a class="nounderline abstract_t">Terruzzi V, Radaelli F, Meucci G, Minoli G. Is the supine position as safe and effective as the prone position for endoscopic retrograde cholangiopancreatography? A prospective randomized study. Endoscopy 2005; 37:1211.</a></li><li><a class="nounderline abstract_t">Ferreira LE, Baron TH. Comparison of safety and efficacy of ERCP performed with the patient in supine and prone positions. Gastrointest Endosc 2008; 67:1037.</a></li><li><a class="nounderline abstract_t">Park TY, Choi SH, Yang YJ, et al. The efficacy and safety of the left lateral position for endoscopic retrograde cholangiopancreatography. Saudi J Gastroenterol 2017; 23:296.</a></li><li><a class="nounderline abstract_t">ASGE Technology Committee, Lo SK, Fujii-Lau LL, et al. The use of carbon dioxide in gastrointestinal endoscopy. Gastrointest Endosc 2016; 83:857.</a></li><li><a class="nounderline abstract_t">Zhang WY, Jiang XP, Miao L, et al. Efficacy and safety of carbon dioxide insufflation versus air insufflation for endoscopic retrograde cholangiopancreatography: A meta-analysis update. Clin Res Hepatol Gastroenterol 2017; 41:217.</a></li><li><a class="nounderline abstract_t">Passos ML, Ribeiro IB, de Moura DTH, et al. Efficacy and safety of carbon dioxide insufflation versus air insufflation during endoscopic retrograde cholangiopancreatography in randomized controlled trials: a systematic review and meta-analysis. Endosc Int Open 2019; 7:E487.</a></li><li><a class="nounderline abstract_t">Luigiano C, Ferrara F, Pellicano R, et al. Carbon dioxide insufflation versus air insufflation during endoscopic retrograde cholangiopancreatography under general anesthesia. Minerva Med 2011; 102:261.</a></li><li><a class="nounderline abstract_t">Bretthauer M, Seip B, Aasen S, et al. Carbon dioxide insufflation for more comfortable endoscopic retrograde cholangiopancreatography: a randomized, controlled, double-blind trial. Endoscopy 2007; 39:58.</a></li><li><a class="nounderline abstract_t">Dellon ES, Velayudham A, Clarke BW, et al. A randomized, controlled, double-blind trial of air insufflation versus carbon dioxide insufflation during ERCP. Gastrointest Endosc 2010; 72:68.</a></li><li><a class="nounderline abstract_t">Nakamura K, Yamaguchi Y, Hasue T, et al. The usefulness and safety of carbon dioxide insufflation during endoscopic retrograde cholangiopancreatography in elderly patients: a prospective, double-blind, randomized, controlled trial. Hepatogastroenterology 2014; 61:2191.</a></li><li><a class="nounderline abstract_t">Ferreira LE, Topazian MD, Harmsen WS, et al. Dietary approaches following endoscopic retrograde cholangiopancreatography: A survey of selected endoscopists. World J Gastrointest Endosc 2010; 2:397.</a></li><li><a class="nounderline abstract_t">Park CH, Jung JH, Hyun B, et al. Safety and efficacy of early feeding based on clinical assessment at 4 hours after ERCP: a prospective randomized controlled trial. Gastrointest Endosc 2018; 87:1040.</a></li><li><a class="nounderline abstract_t">Siiki A, Tamminen A, Tomminen T, Kuusanmäki P. ERCP procedures in a Finnish community hospital: a retrospective analysis of 1207 cases. Scand J Surg 2012; 101:45.</a></li><li><a class="nounderline abstract_t">Kapral C, Mühlberger A, Wewalka F, et al. Quality assessment of endoscopic retrograde cholangiopancreatography: results of a running nationwide Austrian benchmarking project after 5 years of implementation. Eur J Gastroenterol Hepatol 2012; 24:1447.</a></li><li><a class="nounderline abstract_t">Kienbauer M, Duller C, Gschwantler M, et al. [Austrian benchmarking project for ERCP: a 10-year report]. Z Gastroenterol 2018; 56:1227.</a></li><li><a class="nounderline abstract_t">Glomsaker T, Hoff G, Kvaløy JT, et al. Patterns and predictive factors of complications after endoscopic retrograde cholangiopancreatography. Br J Surg 2013; 100:373.</a></li><li><a class="nounderline abstract_t">Köksal AŞ, Eminler AT, Parlak E. Biliary endoscopic sphincterotomy: Techniques and complications. World J Clin Cases 2018; 6:1073.</a></li><li><a class="nounderline abstract_t">Ryozawa S, Itoi T, Katanuma A, et al. Japan Gastroenterological Endoscopy Society guidelines for endoscopic sphincterotomy. Dig Endosc 2018; 30:149.</a></li><li><a class="nounderline abstract_t">Lieber SR, Heller BJ, Martin CF, et al. Complications of Anesthesia Services in Gastrointestinal Endoscopic Procedures. Clin Gastroenterol Hepatol 2020; 18:2118.</a></li><li><a class="nounderline abstract_t">ASGE Training Committee, Jorgensen J, Kubiliun N, et al. Endoscopic retrograde cholangiopancreatography (ERCP): core curriculum. Gastrointest Endosc 2016; 83:279.</a></li><li><a class="nounderline abstract_t">ASGE Standards of Practice Committee, Faulx AL, Lightdale JR, et al. Guidelines for privileging, credentialing, and proctoring to perform GI endoscopy. Gastrointest Endosc 2017; 85:273.</a></li><li><a class="nounderline abstract_t">Trap R, Adamsen S, Hart-Hansen O, Henriksen M. Severe and fatal complications after diagnostic and therapeutic ERCP: a prospective series of claims to insurance covering public hospitals. Endoscopy 1999; 31:125.</a></li><li><a class="nounderline abstract_t">Cotton PB. Analysis of 59 ERCP lawsuits; mainly about indications. Gastrointest Endosc 2006; 63:378.</a></li><li><a class="nounderline abstract_t">Hernandez LV, Klyve D, Regenbogen SE. Malpractice claims for endoscopy. World J Gastrointest Endosc 2013; 5:169.</a></li><li><a class="nounderline abstract_t">Stone AB, Brovman EY, Greenberg P, Urman RD. A medicolegal analysis of malpractice claims involving anesthesiologists in the gastrointestinal endoscopy suite (2007-2016). J Clin Anesth 2018; 48:15.</a></li></ol></div><div id="topicVersionRevision">Topic 632 Version 33.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27546389" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Adverse events associated with ERCP.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23793659" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Endoscopic retrograde cholangiopancreatography: utilisation and outcomes in a 10-year population-based cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Appropriate use of GI endoscopy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25448869" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Quality indicators for ERCP.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34023065" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : ASGE guideline on the management of cholangitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19275689" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Adverse reactions to iodinated contrast media administered at the time of endoscopic retrograde cholangiopancreatography (ERCP).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29666785" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Risk Evaluation of Endoscopic Retrograde Cholangiopancreatography-Related Contrast Media Allergic-Like Reaction: A Single Centre Experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18058651" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : No difference between supine and prone position for ERCP in conscious sedated patients: a prospective randomized study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16329019" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Is the supine position as safe and effective as the prone position for endoscopic retrograde cholangiopancreatography? A prospective randomized study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18206877" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Comparison of safety and efficacy of ERCP performed with the patient in supine and prone positions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28937025" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : The efficacy and safety of the left lateral position for endoscopic retrograde cholangiopancreatography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26946413" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : The use of carbon dioxide in gastrointestinal endoscopy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27840031" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Efficacy and safety of carbon dioxide insufflation versus air insufflation for endoscopic retrograde cholangiopancreatography: A meta-analysis update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31041365" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Efficacy and safety of carbon dioxide insufflation versus air insufflation during endoscopic retrograde cholangiopancreatography in randomized controlled trials: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21959700" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Carbon dioxide insufflation versus air insufflation during endoscopic retrograde cholangiopancreatography under general anesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17252462" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Carbon dioxide insufflation for more comfortable endoscopic retrograde cholangiopancreatography: a randomized, controlled, double-blind trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20493485" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : A randomized, controlled, double-blind trial of air insufflation versus carbon dioxide insufflation during ERCP.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25699348" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : The usefulness and safety of carbon dioxide insufflation during endoscopic retrograde cholangiopancreatography in elderly patients: a prospective, double-blind, randomized, controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21191513" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Dietary approaches following endoscopic retrograde cholangiopancreatography: A survey of selected endoscopists.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28964747" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Safety and efficacy of early feeding based on clinical assessment at 4 hours after ERCP: a prospective randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22414468" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : ERCP procedures in a Finnish community hospital: a retrospective analysis of 1207 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23114747" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Quality assessment of endoscopic retrograde cholangiopancreatography: results of a running nationwide Austrian benchmarking project after 5 years of implementation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30107618" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : [Austrian benchmarking project for ERCP: a 10-year report].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23225493" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Patterns and predictive factors of complications after endoscopic retrograde cholangiopancreatography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30613665" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Biliary endoscopic sphincterotomy: Techniques and complications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29247546" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Japan Gastroenterological Endoscopy Society guidelines for endoscopic sphincterotomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31622738" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Complications of Anesthesia Services in Gastrointestinal Endoscopic Procedures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26708081" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Endoscopic retrograde cholangiopancreatography (ERCP): core curriculum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28089029" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Guidelines for privileging, credentialing, and proctoring to perform GI endoscopy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10223360" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Severe and fatal complications after diagnostic and therapeutic ERCP: a prospective series of claims to insurance covering public hospitals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16500382" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Analysis of 59 ERCP lawsuits; mainly about indications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23596540" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Malpractice claims for endoscopy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29702358" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : A medicolegal analysis of malpractice claims involving anesthesiologists in the gastrointestinal endoscopy suite (2007-2016).</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
